Net Asset Value(s)
October 28, 2024 07:05 ET
|
WisdomTree Issuer ICAV
WisdomTree Issuer plc – Daily Fund Prices 25-October-24 WisdomTree Artificial Intelligence UCITS ETF - USD Acc25/10/2024IE00BDVPNG1312191630USD784,640,082.3564.3589WisdomTree...
Legible Releases FrankensteinAI with Spellbinding AI Chat Feature Just in Time for Halloween
October 28, 2024 07:04 ET
|
Legible
Legible’s FrankensteinAI brings Shelley's classic to life with interactive AI chat and artwork, allowing readers to engage with characters as never before.
Unicycive Therapeutics Delivers Multiple Poster Presentations Highlighting Development Progress on Oxylanthanum Carbonate (OLC) and UNI-494 at the American Society of Nephrology (ASN) Kidney Week 2024
October 28, 2024 07:03 ET
|
Unicycive Therapeutics, Inc.
– Late-Breaker Poster Presentation Highlights Favorable Safety & Tolerability of OLC – – Two Publications Recently Issued Featuring OLC and UNI-494 – LOS ALTOS, Calif., Oct....
Gilat Received Over $4 Million Order from the US Department of Defense
October 28, 2024 07:02 ET
|
Gilat Satellite Networks Ltd.
PETAH TIKVA, Israel, Oct. 28, 2024 (GLOBE NEWSWIRE) -- Gilat Satellite Networks Ltd. (Nasdaq: GILT, TASE: GILT), a worldwide leader in satellite networking technology, solutions and services,...
Fractyl Health to Present Compelling Weight Maintenance Data from both Revita® and Rejuva® Platforms at ObesityWeek® 2024
October 28, 2024 07:00 ET
|
Fractyl Health, Inc.
Fractyl Health to Present Compelling Weight Maintenance Data from both Revita® and Rejuva® Platforms at ObesityWeek® 2024
Evoke Pharma & EVERSANA Announce Statistically Significant Improvement in Patient Outcomes for GLP-1 users with Diabetic Gastroparesis using GIMOTI®
October 28, 2024 07:00 ET
|
Evoke Pharma, Inc.
Analysis of real-world data compared patients on GIMOTI (n=51) to Oral Metoclopramide (n=41), both taking GLP-1s, showing significant statistical improvement for GIMOTI over Oral Metoclopramide in All...
EyePoint Pharmaceuticals Announces Positive Interim 16-Week Data for Ongoing Phase 2 VERONA Clinical Trial of DURAVYU™ for Diabetic Macular Edema
October 28, 2024 07:00 ET
|
EyePoint Pharmaceuticals, Inc.
- DURAVYU 2.7mg demonstrated an early and sustained improvement in BCVA with a gain of +8.9 letters compared to baseline - – DURAVYU 2.7mg demonstrated an early and sustained anatomical improvement...
Bitfarms Appoints Rachel Silverstein as U.S. General Counsel
October 28, 2024 07:00 ET
|
Bitfarms Ltd.
This news release constitutes a “designated news release” for the purposes of the Company’s prospectus supplement dated March 8, 2024, to its short form base shelf prospectus dated November 10, 2023. ...
Local News Live Announces Election Night Coverage
October 28, 2024 07:00 ET
|
Gray Media
ATLANTA, Oct. 28, 2024 (GLOBE NEWSWIRE) -- Gray Media (NYSE: GTN) today announced comprehensive election night coverage plans on Local News Live, its 24/7 news network. Starting at 7 p.m. EST on...
Amicus Therapeutics to Announce Third Quarter 2024 Financial Results on November 6, 2024
October 28, 2024 07:00 ET
|
Amicus Therapeutics, Inc.
PRINCETON, N.J., Oct. 28, 2024 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that the Company will host a conference call and live audio webcast on Wednesday, November 6,...